TIS 0.00% 0.0¢ tissue therapies limited

Well done Sherlock, Guido and others who sat up all night to get...

  1. 472 Posts.
    lightbulb Created with Sketch. 12
    Well done Sherlock, Guido and others who sat up all night to get a first look at the agenda.

    I guess I shouldn't have been taken by surprise on about this as it seems that anything can and will happen with regard to VG BUT this is quite a curve ball. I was expecting VG to appear on the agenda in the usual place but to find out that it is actually set down for an 'oral examination' has come out of nowhere. It would be reasonable to assume that TIS has been notified well in advance that they will be required to attend for the examination but I don't recall any announcement to that effect. Alternatively if they weren't notified then one's mind turns to all sorts of conspiracy theories.

    In short we were all set to find out if there was an opinion to be adopted at this month's meeting or that there were more issues to be answered. Now we are left with a whole lot of uncertainty about what could happen as a result of the examination. The market doesn't like uncertainty so I hope the company can release an announcement soon about what transpired and what we can expect over the coming months.

    I have done a quick look back through the last few months of oral examinations and it appears that what most often happens is that the product receives a positive opinion in the following month's meeting. However, it appears that is not always the case. Unfortunately I don't have time at the moment to do a detailed analysis. DYOR seems to be suggesting that in some cases a positive opinion was given at the same meeting as the examination but I haven't found a case of that happening in the last few months. Maybe he has done a more detailed analysis. DYOR are you able to give any figures??

    So who knows what's going on? I sure don't! I'll change my sentiment to hold for now whereas I fully intended to move to 'sell' on indication of further delay or 'buy' for a likely positive opinion.

    Rev
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.